|
Volumn 12, Issue 12, 2011, Pages 2080-
|
TGF-β as target in oncology
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACTIVIN RECEPTOR LIKE KINASE 1;
ENDOGLIN;
TRABEDERSEN;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA RECEPTOR;
TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;
TRANSFORMING GROWTH FACTOR BETA1;
TRANSFORMING GROWTH FACTOR BETA2;
TRANSFORMING GROWTH FACTOR BETA3;
ANGIOGENESIS;
ANTIBODY RESPONSE;
ANTIGEN PRESENTING CELL;
ANTINEOPLASTIC ACTIVITY;
B LYMPHOCYTE;
BONE METASTASIS;
BREAST CANCER;
CANCER GRADING;
CANCER GROWTH;
CANCER INVASION;
CANCER PATIENT;
CANCER THERAPY;
CARCINOGENESIS;
CELL MOTILITY;
DRUG INDUSTRY;
DRUG TARGETING;
EDITORIAL;
ENZYME INHIBITION;
GLIOMA;
HUMAN;
IMMUNE DEFICIENCY;
MELANOMA;
METASTASIS;
NONHUMAN;
PANCREAS CANCER;
PROTEIN TARGETING;
SIGNAL TRANSDUCTION;
SQUAMOUS CELL CARCINOMA;
T LYMPHOCYTE;
ANIMALS;
HUMANS;
NEOPLASMS;
TRANSFORMING GROWTH FACTOR BETA;
|
EID: 84855213901
PISSN: 13892010
EISSN: 18734316
Source Type: Journal
DOI: 10.2174/138920111798808220 Document Type: Editorial |
Times cited : (2)
|
References (0)
|